Skip to main content

Table 1 Patient characteristics

From: Subclinical synovitis detected by macrophage PET, but not MRI, is related to short-term flare of clinical disease activity in early RA patients: an exploratory study

Baseline characteristic

Value

Female

13 (52 %)

Age (years)

53 (13)

Disease duration (months)

9.0 (7.0–15.0)

ESR (mm/hour)

5.0 (2.0–7.5)

CRP (mg/L)

2.5 (1.0–5.0)

VAS general health (0–100 mm)

5.0 (1.0–24.5)

Tender joint count

0

Swollen joint count

0

DAS in 44 joints

0.7 (0.3)

2011 Boolean ACR/EULAR remission

18 (72 %)

ACPA-positive

18 (72 %)

RF-positive

16 (64 %)

Medication

 

 MTX

12 (48 %)

 MTX + SSZ

8 (32 %)

 LFL

1 (4 %)

 MTX + etanercept

2 (8 %)

 MTX + SSZ + etanercept

2 (8 %)

 Prednisolone (maximum 7.5 mg per day)

16 (64 %)

  1. Data presented as number (%), mean (standard deviation), or median (interquartile range). n = 25
  2. ACR American College of Rheumatology; CRP C-reactive protein, DAS Disease Activity Score, EULAR European League Against Rheumatism, LFL leflunomide, MTX methotrexate, RF rheumatoid factor; SSZ sulfasalazine, VAS visual analog scale